PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31072180-6	2019	CONCLUSION: Montelukast combined with methylprednisolone for the treatment of mycoplasma pneumonia can inhibit inflammatory responses and regulate levels of Th1/Th2 and Th17/Treg cells.	montelukast	12-23	negative elongation factor complex member C/D	Homo sapiens	157-160	
17653314-7	2007	Both Singulair and budesonide aerosol could correct the imbalance of Th1 and Th2 cytokines.	montelukast	5-14	negative elongation factor complex member C/D	Homo sapiens	69-72	
15897161-12	2005	Treatment with montelukast may also be associated with deviation of the immune system towards the Th1-specific pathway.	montelukast	15-26	negative elongation factor complex member C/D	Homo sapiens	98-101	
14653048-3	2003	OBJECTIVE: Aim of the study was to evaluate the modulation by the antileukotriene montelukast on Th2 and Th1 cytokines in allergic rhinitis.	montelukast	82-93	negative elongation factor complex member C/D	Homo sapiens	105-108	
14653048-7	2003	CONCLUSIONS: Montelukast treatment reversed a typical Th2 cytokine pattern (IL4 and IL13) toward a Th1 (IFN gamma) predominance in children with PAR and EIA.	montelukast	13-24	negative elongation factor complex member C/D	Homo sapiens	99-102